查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1985968

美国外骨骼市场规模、份额和趋势分析报告：按移动性、技术、目标部位、应用、地区和细分市场划分，预测期为2026-2033年

U.S. Exoskeleton Market Size, Share & Trends Analysis Report By Mobility, By Technology, By Extremity, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

美国外骨骼市场概述

据估计，2025 年美国外骨骼市场价值为 2.3418 亿美元，预计到 2033 年将达到 6.4025 亿美元，2026 年至 2033 年的复合年增长率为 13.09%。

美国外骨骼产业的主要成长动力来自老年人口的快速成长、汽车、军事、国防和建筑等产业对医疗设备日益普及以及中风的发病率的上升。

创伤性脊髓损伤（SCI）发病率的上升预计将推动美国市场的需求成长。例如，美国脊髓协会在2025年9月报告称，美国有25万至39万人患有脊髓损伤，每年新增病例约1.8万例。主要病因是车祸和跌倒。该协会还强调了常见的继发性併发症，包括忧郁症、慢性疼痛、痉挛、压疮以及肠道、膀胱和呼吸问题。

外骨骼解决方案的应用日益普及，尤其是在帮助脊髓损伤患者恢復行动能力和进行復健方面。在美国，穿戴式机器人领域的持续创新正推动製造商推出具有更强个人化和数位化整合能力的下一代系统。例如，Lifeward Ltd. 于 2025 年宣布其最新个人外骨骼「ReWalk 7」在全美范围内上市。这款新系统融合了云端连接、自适应软体和步行速度调节等先进功能，为脊髓损伤使用者提供更细緻入微的步行体验。此次发布体现了该公司致力于提升美国市场外骨骼辅助步行解决方案的用户自主性、临床疗效和实际应用价值的策略重点。

「经过数年的研发，ReWalk 7 应运而生，它融合了先进的技术创新以及来自临床医生和患者的反馈，旨在进一步提升 ReWalk 行业领先的全球声誉。最终打造出一款针对实际使用进行优化的设备，提供无与伦比的用户体验和行动自由。我们非常高兴能为全美瘫痪日常生活患者提供一种新的选择，帮助他们将行走首席执行官——瘫痪日常生活患者——瘫痪日常生活患者提供一种新的选择，帮助他们将行走首席执行官——他非常高兴能为全美瘫痪日常生活患者提供一种新的选择，帮助他们将行走首席执行官——他非常高兴能融入日常生活患者——瘫痪日常生活患者的一种新的选择，帮助他们将 Larrys 融入日常生活。

创伤性脊髓损伤（TRAS）发病率的上升正在推动美国外骨骼市场的成长。这是因为外骨骼被推荐用于缓解脊髓损伤患者的症状。这是促使患者和医疗专业人员采用外骨骼的主要因素。例如，根据美国国家脊髓损伤统计中心（NSCISC）2024年的数据，创伤性脊髓损伤仍然是美国一个重要的公共卫生问题，根据最新估计，每年新增病例约18,400例。这一数字相当于每百万人每年约有54例新诊断病例，凸显了一般人群中持续存在的严重脊髓损伤风险。这些损伤的持续发生反映了人们持续暴露于交通事故、跌倒、运动伤害和职场等因素，导致需要长期復健、行动辅助和先进辅助技术的患者群体持续存在。

在建设业等体力劳动强度大的产业中，最常见的肌肉骨骼损伤和疾病包括职业过度使用症候群（OOS）、累积创伤障碍（CTD）和重复性劳损（RSI）。这些疾病是由重复性动作、搬运重物、不自然的姿势以及工作中长时间过度劳累造成的。根据美国劳工统计局截至2023年8月的最新数据，2021年至2022年间，美国报告的职场肌肉骨骼疾病病例估计为502,380例，发病率约为每10,000名全职员工25.3例。这显示这些损伤在美国各行各业普遍存在。

此外，根据WorkCare公司2025年3月发表的报导，更广泛的估计表明，在美国，每年有超过一百万起与工作相关的伤害是由肌肉骨骼疾病引起的，给雇主和员工都带来了沉重的负担。职业性肌肉骨骼疾病的高发生率是推动外骨骼解决方案日益普及的主要动力，因为这项技术有助于辅助和支持体力劳动，改善工人的健康状况和生产力，并减轻产业工人的疲劳。

美国外骨骼市场的快速技术进步正在推动创新，并加速其在医疗、工业和消费领域的应用。例如，2026年1月，美国外骨骼领域的一项重大进展是在CES 2026等重要展会上发布了新型人工智慧驱动的可穿戴机器人系统。多家公司展示了新一代便携式外骨骼，这些外骨骼整合了即时人工智慧辅助功能，包括地形自适应控制，并采用紧凑、以用户为中心的设计，支援用户多样化的移动方式，并减轻身体负担。这些产品代表着外骨骼解决方案正朝着更智慧和适应性强的方向发展，旨在辅助完成从日常出行到高强度任务的各种工作，反映了美国可携式机器人领域日益增长的兴趣和商业性势头。

目录

第一章：调查方法和范围

第二章执行摘要

第三章：美国外骨骼市场的影响因素、趋势与范围

  • 市场历史及展望
    • 母市场展望
  • 市场动态
  • 外骨骼市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析
  • 美国外骨骼/外骨骼机器人市场的主要趋势
  • 美国外骨骼/外骨骼机器人市场的主要发展动态
  • 美国外骨骼/外骨骼机器人市场专利分析
  • 案例研究与见解
  • 外骨骼供应链分析
  • 当前监管趋势分析
  • 生态系分析
  • 价格分析
  • 未来市场创新

第四章：2021-2033年美国外骨骼市场按移动类型分類的销售量（千台）

  • 定义和范围
  • 依行程类型分類的市占率分析（2025 年和 2033 年）
  • 美国外骨骼市场：依移动能力划分，2021-2033年
  • 美国外骨骼市场规模及预测：以移动方式划分，2021-2033年
  • 美国外骨骼市场规模及预测：依移动类型、销售量划分，2021-2033 年（千台）
  • 手机类型
  • 固定式/独立式

第五章：美国外骨骼市场細項分析（依技术划分，2021-2033 年，销售量，单位：千台）

  • 定义和范围
  • 按技术分類的市场份额分析（2025 年和 2033 年）
  • 美国外骨骼市场：依技术划分，2021-2033年
  • 美国外骨骼市场规模及预测：依技术划分，2021-2033年
  • 美国外骨骼市场规模及预测：依技术、销售划分，2021-2033 年（千台）
  • 动力
  • 无动力

第六章：美国外骨骼市场区隔（依肢体划分），2021-2033年，销售量（千台）

  • 定义和范围
  • 按行业分類的市场份额分析（2025 年和 2033 年）
  • 美国外骨骼市场：依肢体划分，2021-2033 年
  • 美国外骨骼市场规模及预测：依肢体划分，2021-2033年
  • 美国外骨骼市场规模及预测（依肢体划分，销售量，2021-2033 年，单位：千台）
  • 上半身
  • 下半身
  • 全身

第七章：美国外骨骼市场：依最终用途分類的估算与趋势分析

    • 定义和范围
  • 按最终用途分類的市场份额分析（2025 年和 2033 年）
  • 美国外骨骼市场：依应用领域划分，2021-2033年
  • 美国外骨骼市场规模及预测：依最终用途划分，2021-2033年
  • 美国外骨骼市场规模及预测：依最终用途及销售划分，2021-2033 年（千台）
  • 医疗保健
    • 2021-2033年医疗保健市场估算与预测
  • 军队
    • 军事市场估计与预测（2021-2033）
  • 产业
    • 2021-2033年工业市场估算与预测

第八章 竞争情势

  • 近期趋势及影响分析：依主要市场参与企业
  • 公司/竞争对手分类
  • 美国外骨骼/外骨骼机器人市场关键绩效指标
  • 公司简介
    • Ekso Bionics
    • Lockheed Martin Corporation
    • Suit X
    • Rex Bionics Plc.
    • ReWalk Robotics
    • DIH Medical
    • German Bionic
    • Sarcos Technology and Robotics Corporation
    • Parker Hannifin Corporation
    • Bionik Laboratories
Product Code: GVR-4-68040-858-0

U.S. Exoskeleton Market Summary

The U.S. exoskeleton market size was estimated at USD 234.18 million in 2025 and is projected to reach USD 640.25 million by 2033, growing at a CAGR of 13.09% from 2026 to 2033. The rapidly growing geriatric population, rising adoption of medical devices across industries such as automotive, military, defense, and construction, and the rising incidence of stroke are key drivers of growth in the U.S. exoskeleton industry.

The growing incidence rate of traumatic spinal cord injuries (SCI) is expected to drive the demand across U.S. markets. For instance, in September 2025, the United Spinal Association reported that 250,000 to 390,000 people in the U.S. are living with spinal cord injury, with about 18,000 new cases each year, most often due to vehicle accidents and falls. It highlighted common secondary complications, including depression, chronic pain, spasticity, pressure injuries, and bowel, bladder, and respiratory issues.

Exoskeleton solutions are increasingly being adopted to support mobility restoration and rehabilitation, particularly for individuals with spinal cord injuries. In the U.S., ongoing innovation in wearable robotics is encouraging manufacturers to introduce next-generation systems with improved personalization and digital integration. For instance, in 2025, Lifeward Ltd. announced the nationwide U.S. commercialization of its latest personal exoskeleton, ReWalk 7. The new system incorporates advanced features such as cloud-based connectivity, adaptive software, and adjustable walking speeds, enabling a more tailored gait experience for users with spinal cord injuries. This launch reflects the company's strategic focus on enhancing user autonomy, clinical outcomes, and real-world usability of exoskeleton-assisted walking solutions in the U.S. market.

"The ReWalk 7 was developed over several years, integrating advanced technological innovations with feedback from clinicians and patients to build upon the ReWalk's world-class reputation for industry leadership, The result is a device that is optimized for real-world use, with an unmatched user experience and freedom of movement. We are thrilled to be able to provide paralyzed individuals across the country with a new option for integrating walking to everyday life." -Larry Jasinski, CEO of Lifeward

The increasing prevalence of traumatic spinal cord injury is boosting the growth of the U.S. exoskeleton market, as patients suffering from spinal cord injury are recommended to use an exoskeleton to improve their condition. This has become a key driver for the adoption of exoskeletons by patients and healthcare providers. For instance, as per the National Spinal Cord Injury Statistical Center (NSCISC) in 2024, in the U.S., traumatic spinal cord injury remains a significant public health concern, with recent estimates indicating that approximately 18,400 new cases are reported each year. This incident corresponds to around 54 newly diagnosed individuals per one million people annually, underscoring the persistent risk of severe spinal trauma across the population. The steady occurrence of these injuries reflects ongoing exposure to factors such as road traffic accidents, falls, sports-related injuries, and workplace incidents, contributing to a sustained patient pool requiring long-term rehabilitation, mobility assistance, and advanced supportive technologies.

Some of the most common musculoskeletal injuries and disorders affecting workers in physically demanding sectors such as construction include occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI). These conditions arise from repetitive motions, heavy lifting, awkward postures, and prolonged exertion on the job. According to the most recent data from the U.S. Bureau of Labor Statistics in August 2023, an estimated 502,380 workplace musculoskeletal disorder cases were reported over the 2021-2022 period, with an incidence rate of about 25.3 cases per 10,000 full-time equivalent workers, illustrating the widespread nature of these injuries across U.S. industries.

In addition, as per the WorkCare, Inc. article published in March 2025, broader estimates suggest that musculoskeletal disorders account for over 1 million workplace injuries in the U.S. annually, placing a substantial burden on employers and workers alike. These high rates of work-related musculoskeletal issues are key drivers for the growing adoption of exoskeleton solutions, as such technology can help augment or support physical tasks, improve worker health and productivity, and reduce fatigue among industrial laborers.

Rapid technological advancements in the U.S. exoskeleton market are driving innovation, accelerating adoption across health care, industrial, and consumer segments. For instance, in January 2026, a key development in the U.S. is the recent unveiling of new AI-enabled wearable robotic systems at major trade events such as CES 2026, where several companies showcased next-generation portable exoskeletons that incorporate real-time AI-driven assistance, including terrain adaptive controls and compact, user-centric designs that support mobility and reduce physical exertion for diverse users. These products signal a shift toward more intelligent, adaptive exoskeleton solutions designed to assist both daily mobility and demanding tasks, reflecting growing interest and commercial momentum in the U.S. wearable robotics space.

U.S. Exoskeleton Market Report Segmentation

This report forecasts revenue and volume growth at the country level and provides an analysis of industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the U.S. exoskeleton market report based on mobility, technology, extremity, end-use, and region:

  • Mobility Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Mobile
  • Fixed/Stationary
  • Technology Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Powered
  • Non-powered
  • Extremity Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Upper Body
  • Lower Body
  • Full Body
  • End-use Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)
  • Healthcare
  • Military
  • Industry

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Mobility
    • 1.2.2. Technology
    • 1.2.3. Extremity
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Mobility outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Extremity outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Exoskeleton Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of spinal cord injury
      • 3.2.1.2. Increasing incidence of musculoskeletal disorders
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High procedural costs
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Exoskeleton Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape
  • 3.4. Key Trends in the U.S. Exoskeleton/Exo Robots Market
  • 3.5. Key Developments in the U.S. Exoskeleton/Exo Robots Market
  • 3.6. Patent Analysis in the U.S. Exoskeleton/Exo Robots Market
  • 3.7. Case Studies & Insights
  • 3.8. Supply Chain Analysis for Exoskeletons
  • 3.9. Current Regulatory Analysis
  • 3.10. Ecosystem Analysis
  • 3.11. Pricing Analysis
  • 3.12. Upcoming Innovations in the Market

Chapter 4. U.S. Exoskeleton Market Segment Analysis, By Mobility 2021-2033 (USD Million), Unit Volume (000' Units)

  • 4.1. Definition and Scope
  • 4.2. Mobility Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. U.S. Exoskeleton Market, By Mobility, 2021 - 2033
  • 4.5. U.S. Exoskeleton Market Size & Forecasts, By Mobility, 2021 - 2033 (USD Million)
  • 4.6. U.S. Exoskeleton Market Size & Forecasts, By Mobility, Unit Volume, 2021 - 2033 (000' Units)
  • 4.7. Mobile
    • 4.7.1. Mobile market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 4.8. Fixed/Stationary
    • 4.8.1. Fixed/stationary market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)

Chapter 5. U.S. Exoskeleton Market Segment Analysis, By Technology 2021-2033 (USD Million), Unit Volume (000' Units)

  • 5.1. Definition and Scope
  • 5.2. Technology Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. U.S. Exoskeleton Market, By Technology, 2021 - 2033
  • 5.5. U.S. Exoskeleton Market Size & Forecasts, By Technology, 2021 - 2033 (USD Million)
  • 5.6. U.S. Exoskeleton Market Size & Forecasts, By Technology, Unit Volume, 2021 - 2033 (000' Units)
  • 5.7. Powered
    • 5.7.1. Powered market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
    • 5.7.2. Powered by Extremity
      • 5.7.2.1. Upper body
        • 5.7.2.1.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
      • 5.7.2.2. Lower body
        • 5.7.2.2.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
      • 5.7.2.3. Full body
        • 5.7.2.3.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 5.8. Non-Powered
    • 5.8.1. Non-powered market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
    • 5.8.2. Non-powered by Extremity
      • 5.8.2.1. Upper body
        • 5.8.2.1.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
      • 5.8.2.2. Lower body
        • 5.8.2.2.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
      • 5.8.2.3. Full body
        • 5.8.2.3.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)

Chapter 6. U.S. Exoskeleton Market Segment Analysis, By Extremity 2021-2033 (USD Million), Unit Volume (000' Units)

  • 6.1. Definition and Scope
  • 6.2. Extremity Market Share Analysis, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. U.S. Exoskeleton Market, By Extremity, 2021 - 2033
  • 6.5. U.S. Exoskeleton Market Size & Forecasts, By Extremity, 2021 - 2033 (USD Million)
  • 6.6. U.S. Exoskeleton Market Size & Forecasts, By Extremity, Unit Volume, 2021 - 2033 (000' Units)
  • 6.7. Upper Body
    • 6.7.1. Upper body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 6.8. Lower Body
    • 6.8.1. Lower body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 6.9. Full Body
    • 6.9.1. Full body market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)

Chapter 7. U.S. Exoskeleton Market: End Use Estimates & Trend Analysis

      • Definition and Scope
  • 7.1. End Use Market Share Analysis, 2025 & 2033
  • 7.2. Segment Dashboard
  • 7.3. U.S. Exoskeleton Market, By End Use, 2021 - 2033
  • 7.4. U.S. Exoskeleton Market Size & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 7.5. U.S. Exoskeleton Market Size & Forecasts, By End Use, Unit Volume, 2021 - 2033 (000' Units)
  • 7.6. Healthcare
    • 7.6.1. Healthcare market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 7.7. Military
    • 7.7.1. Military market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)
  • 7.8. Industry
    • 7.8.1. Industry market estimates and forecasts 2021 to 2033 (USD Million, 000' Units)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. U.S. Exoskeleton/Exo Robots Key Market Performance Indicators
  • 8.4. Company Profiles
    • 8.4.1. Ekso Bionics
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Lockheed Martin Corporation
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Suit X
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Rex Bionics Plc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. ReWalk Robotics
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. DIH Medical
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. German Bionic
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Sarcos Technology and Robotics Corporation
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Parker Hannifin Corporation
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Bionik Laboratories
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. exoskeleton market estimates and forecasts, by mobility, 2021 - 2033 (USD Million)
  • Table 4 U.S. exoskeleton market volume estimates and forecasts, by mobility, 2021 - 2033 (Volume, 000' Units)
  • Table 5 U.S. exoskeleton market estimates and forecasts, by technology, 2021 - 2033 (USD Million)
  • Table 6 U.S. exoskeleton market volume estimates and forecasts, by technology, 2021 - 2033 (Volume, 000' Units)
  • Table 7 U.S. exoskeleton market estimates and forecasts, by extremity, 2021 - 2033 (USD Million)
  • Table 8 U.S. exoskeleton market volume estimates and forecasts, by extremity, 2021 - 2033 (Volume, 000' Units)
  • Table 9 U.S. exoskeleton market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. exoskeleton market volume estimates and forecasts, by end use, 2021 - 2033 (Volume, 000' Units)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. exoskeleton market: market outlook
  • Fig. 7 U.S. exoskeleton competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 U.S. exoskeleton market driver impact
  • Fig. 11 U.S. exoskeleton market restraint impact
  • Fig. 12 U.S. exoskeleton market: Mobility movement analysis
  • Fig. 13 U.S. exoskeleton market: Mobility outlook and key takeaways
  • Fig. 14 Mobile market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 15 Fixed/stationary market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 16 U.S. exoskeleton market: Technology movement analysis
  • Fig. 17 U.S. exoskeleton market: Technology outlook and key takeaways
  • Fig. 18 Powered market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 19 Non-powered market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 20 U.S. exoskeleton market: Extremity movement analysis
  • Fig. 21 U.S. exoskeleton market: Extremity outlook and key takeaways
  • Fig. 22 Upper body market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 23 Lower body market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 24 Full body market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 25 U.S. exoskeleton market: End Use movement analysis
  • Fig. 26 U.S. exoskeleton market: End Use outlook and key takeaways
  • Fig. 27 Healthcare market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 28 Military market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)
  • Fig. 29 Industry market estimates and forecast, 2021 - 2033 (USD Million, 000' Units)